| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return | vs S&P 500 ⓘ |
|---|---|---|---|---|---|---|
|
KZIA
Kazia Therapeutics
|
Oct 20, 2026 | BUY |
Strong Buy
+222.3% avg upside
10 analysts
|
$30.00
252.85% Upside
|
-6.0% | · |
|
BLSM
BlossomHill Therapeutics, Inc.
|
Sep 21, 2026 | BUY |
Strong Buy
+157.5% avg upside
5 analysts
|
$40.00
190.98% Upside
|
-42.2% | · |
|
BBOT
BridgeBio Oncology Therapeutics
|
Sep 18, 2026 | BUY |
Strong Buy
+714.3% avg upside
11 analysts
|
$25.00
854.16% Upside
|
-50.3% | · |
|
CMPX
Compass Therapeutics
|
Aug 07, 2026 | BUY |
Strong Buy
+831.7% avg upside
20 analysts
|
$7.00
790.04% Upside
|
-61.4% | · |
|
EXEL
Exelixis
|
Aug 06, 2026 | HOLD |
Buy
-34.0% avg upside
34 analysts
|
$52.00
25.00% Downside
|
+33.8% | · |
|
INCY
Incyte
|
Aug 03, 2026 | BUY |
Buy
-5.9% avg upside
49 analysts
|
$155.00
28.85% Upside
|
+1.6% | · |
|
AGIO
Agios Pharma
|
Jul 07, 2026 | BUY |
Strong Buy
+99.0% avg upside
30 analysts
|
— | -27.2% | · |
|
PBLS
Parabilis Medicines, Inc.
|
Jul 06, 2026 | BUY |
Strong Buy
+47.4% avg upside
7 analysts
|
$40.00
41.22% Upside
|
-3.2% | · |
|
AURA
Aura Biosciences Inc
|
Jun 02, 2026 | BUY |
Strong Buy
+230.6% avg upside
9 analysts
|
— | +11.0% | · |
|
STRO
Sutro Biopharma
|
May 15, 2026 | BUY |
Strong Buy
+357.6% avg upside
22 analysts
|
$43.00
372.53% Upside
|
-73.7% | · |
|
DMRA
Damora Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+39.9% avg upside
20 analysts
|
$51.00
137.29% Upside
|
-3.7% | · |
|
IMNM
Immunome
|
May 15, 2026 | BUY |
Strong Buy
+81.9% avg upside
19 analysts
|
$33.00
81.31% Upside
|
-11.5% | · |
|
TNGX
Tango Therapeutics
|
May 15, 2026 | BUY |
Strong Buy
+76.4% avg upside
16 analysts
|
$55.00
142.04% Upside
|
+22.2% | · |
|
ANL
Adlai Nortye Ltd. Sponsored ADR
|
Mar 20, 2026 | BUY |
Strong Buy
+181.2% avg upside
9 analysts
|
$23.00
140.79% Upside
|
+41.6% | · |
|
RLMD
Relmada Therapeutics
|
Jan 23, 2026 | BUY |
Buy
+273.3% avg upside
15 analysts
|
$8.00
123.56% Upside
|
+13.6% | · |
|
ZYME
Zymeworks
|
Nov 19, 2025 | BUY |
Strong Buy
+18.4% avg upside
26 analysts
|
$40.00
39.85% Upside
|
+17.1% | · |
|
CELC
Celcuity
|
Nov 17, 2025 | BUY |
Strong Buy
+82.6% avg upside
18 analysts
|
$97.00
40.22% Upside
|
-29.7% | · |
|
COGT
Cogent Biosciences
|
Nov 10, 2025 | BUY |
Strong Buy
+24.4% avg upside
26 analysts
|
$50.00
61.26% Upside
|
-2.5% | · |
|
IMRX
Immuneering
|
Oct 31, 2025 | BUY |
Strong Buy
+379.3% avg upside
12 analysts
|
$15.00
300.47% Upside
|
-45.5% | · |
|
IDYA
IDEAYA Biosciences
|
Oct 21, 2025 | HOLD |
Strong Buy
+48.3% avg upside
31 analysts
|
$33.00
3.29% Upside
|
+21.5% | · |
|
CGEM
Cullinan Management
|
Sep 04, 2025 | BUY |
Strong Buy
+135.1% avg upside
16 analysts
|
— | +219.7% | · |
|
OKUR
OnKure Therapeutics
|
Aug 13, 2025 | BUY |
Buy
+743.5% avg upside
13 analysts
|
$33.00
1159.54% Upside
|
+62.5% | · |
|
RLAY
Relay Therapeutics
|
Aug 12, 2025 | BUY |
Strong Buy
+22.4% avg upside
22 analysts
|
$12.00
34.70% Downside
|
+499.1% | · |
|
BOLD
Boundless Bio Inc.
|
Aug 11, 2025 | HOLD |
Buy
+264.4% avg upside
11 analysts
|
$3.00
21.46% Upside
|
+147.8% | · |
|
ZNTL
Zentalis Pharmaceuticals
|
Aug 07, 2025 | HOLD |
Buy
+585.1% avg upside
20 analysts
|
$5.00
155.08% Upside
|
+191.0% | · |
|
ARVN
Arvinas Holding Company
|
Aug 07, 2025 | HOLD |
Buy
+257.9% avg upside
28 analysts
|
$9.00
14.53% Upside
|
+40.2% | · |
|
ONC
BeOne Medicines
|
Aug 07, 2025 | BUY |
Strong Buy
-1.2% avg upside
29 analysts
|
$345.00
6.93% Downside
|
+16.8% | · |
|
HK:2256
Abbisko Cayman Limited
|
Aug 05, 2025 | BUY |
Strong Buy
+261.3% avg upside
3 analysts
|
$18.00
190.75% Upside
|
-14.8% | · |
|
GH
Guardant Health
|
Feb 26, 2025 | BUY |
Strong Buy
-3.1% avg upside
33 analysts
|
— | +126.8% | · |
|
ASH
Ashland
|
Dec 10, 2024 | BUY |
Strong Buy
+7.8% avg upside
16 analysts
|
— | -18.7% | · |
|
CCCC
C4 Therapeutics
|
Feb 07, 2023 | BUY |
Strong Buy
+405.9% avg upside
21 analysts
|
$25.00
641.83% Upside
|
-12.7% | · |
|
GLUE
Monte Rosa Therapeutics
|
Feb 07, 2023 | HOLD |
Strong Buy
+108.5% avg upside
16 analysts
|
$15.00
39.40% Upside
|
-40.0% | · |
|
SVRN
OceanPal Inc
|
Mar 21, 2022 | BUY |
Strong Buy
6 analysts
|
— | · | · |
|
PBYI
Puma Biotechnology
|
May 07, 2021 | HOLD |
Buy
+305.2% avg upside
11 analysts
|
$10.00
4.14% Downside
|
-79.7% | · |
|
NBRVF
Nabriva Therapeutics
|
Jan 17, 2018 | BUY |
Buy
+13374900.0% avg upside
9 analysts
|
$10.00
9999900.06% Upside
|
· | · |
|
RYTM
Rhythm Pharmaceuticals
|
Nov 01, 2017 | HOLD |
Strong Buy
+39.2% avg upside
23 analysts
|
$23.00
75.23% Downside
|
+10.7% | · |
|
OCUL
Ocular Therapeutix
|
Jul 14, 2017 | HOLD |
Strong Buy
+253.9% avg upside
21 analysts
|
$8.00
14.82% Upside
|
+3.6% | · |
|
AKBA
Akebia Therapeutics
|
Jul 18, 2016 | BUY |
Strong Buy
+1184.8% avg upside
16 analysts
|
— | +61.2% | · |
|
RMTI
Rockwell Med
|
Jul 18, 2016 | SELL |
Buy
+93.1% avg upside
11 analysts
|
— | · | · |
|
CG
Carlyle Group
|
Feb 17, 2016 | BUY |
Buy
+30.7% avg upside
26 analysts
|
$20.00
50.26% Downside
|
+24.4% | · |
|
GILD
Gilead Sciences
|
Dec 01, 2014 | HOLD |
Strong Buy
-27.3% avg upside
66 analysts
|
— | +6.1% | · |
|
ENTA
Enanta Pharmaceuticals
|
Dec 01, 2014 | HOLD |
Buy
+206.4% avg upside
17 analysts
|
— | -28.3% | · |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.